Align Technology Prevails in China Patent Infringement Action Against Angelalign
Align Technology, Inc. ("Align") (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, today announced that the Jinan Intermediate People's Court in China issued a judgment in favor of Align in a patent infringement action against Angelalign Technology's operating subsidiaries in China ("Angel") (Hong Kong Stock Exchange: 6699.HK).
Record details
Published: 12 August 2026
Source: ITWeb (ZA)
Category: News
Topics: Healthcare
Retrieved: 14 August 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
China’s ‘brain chip’ drive accelerates with slew of state-backed initiatives
SCMP Tech (HK/CN) · 13 August 2026
Chinese doctor stuns maths world by cracking decades-old problem using ChatGPT
SCMP Tech (HK/CN) · 14 August 2026
Rich Chinese embrace domestic high-end EVs as tech and driving experience eclipse prestige
SCMP Tech (HK/CN) · 14 August 2026
Palantir's Karp renews attacks on frontier AI labs that are 'trying to drug addict us'
CNBC Technology · 3 August 2026
Chinese biotech giant WuXi AppTec sees first-half earnings surge amid US scrutiny
SCMP Tech (HK/CN) · 3 August 2026
Will AI healthcare be China’s new global growth engine?
SCMP Tech (HK/CN) · 3 August 2026
How to cite this record
ethics.ai (12 August 2026), “Align Technology Prevails in China Patent Infringement Action Against Angelalign,” evidence record 19413, https://ethics.ai/record/19413 (originally published by ITWeb (ZA)).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.